Drugs / Tolfenamic Acid
Tolfenamic Acid
also known as
Acide tolfenamique · Acido tolfenamico · Clotam · Clotam rapid · N-(3-chloro-o-tolyl)anthranilic · NSC-757873
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT02159248 | Mar 2014 → Aug 2017 | malignant pancreatic neoplasm | Orlando Health, Inc. | Withdrawn | No outcome recorded Stop: Enrollment |
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT04253132 Comparator | Jan 2021 → Dec 2022 | progressive supranuclear palsy | NeuroTau, Inc. | Unknown | No outcome recorded |
Evidence & citations 9 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tolfenamic Acid | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04253132 ↗ |
| Known as | Acide tolfenamique | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Known as | Acido tolfenamico | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Known as | Clotam | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Known as | Clotam rapid | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Known as | N-(3-chloro-o-tolyl)anthranilic | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Known as | NSC-757873 | ChEMBL registry synonym — accepted as the source's own label CHEMBL121626 ↗ |
| Modality | Small molecule | “Tolfenamic acid is an NSAID closely resembling mefenamic and flufenamic acid.” NCT04253132 ↗ |
| Route | Oral | “200mg of oral tolfenamic acid” NCT02159248 ↗ |